Fulqrum Publishing Home   |   Register   |   Today Posts   |   Members   |   UserCP   |   Calendar   |   Search   |   FAQ

Go Back   Official Fulqrum Publishing forum > Fulqrum Publishing > IL-2 Sturmovik: Cliffs of Dover

IL-2 Sturmovik: Cliffs of Dover Latest instalment in the acclaimed IL-2 Sturmovik series from award-winning developer Maddox Games.

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
  #13  
Old 01-25-2011, 11:59 PM
Robotic Pope's Avatar
Robotic Pope Robotic Pope is offline
Approved Member
 
Join Date: Aug 2009
Location: Hertfordshire,England,UK
Posts: 1,520
Default

Quote:
Originally Posted by Triggaaar View Post
"he will join the Royal Air Force to fight the ..... renegade pilots on his own side."



It's not so much a question of who the renegades were, it's the fact that you are to fight against them. I've seen so many so called explanations of this nonsense. There are only two possible explanations:
1) They've typed it incorrectly - without doubt the most likely explanation
2) The development team have taken leave of their senses and turned the game into a farse - I doubt it.
In situation 2, Ive got the story all sorted lol.
The Germans have created a new secret bio weapon, A mind control virus that becomes known as the Defection Infection. This virus can infect any of your squadron at any time. Who can you trust as your wingman? Will your best friend suddenly start shooting at you? To have any hope of winning this war, You must hold out against an enemy on two sides long enough for the British scientists to come up with a cure.
__________________


XBL GT: - Robotic Pope
HyperLobby CS: - Robot_Pope
Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT. The time now is 08:15 AM.


Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
Copyright © 2007 Fulqrum Publishing. All rights reserved.